MicroRNA-125b in vascular diseases: An updated systematic review of pathogenetic implications and clinical...

Area of Science:

• Vascular Biology
• Epigenetics
• Molecular Medicine

Background:

• Epigenetic modifications, especially non-coding RNAs, are crucial in vascular disease development.
• MicroRNAs (miRNAs) regulate key cellular processes in endothelial and smooth muscle cells.
• MicroRNA-125b (miR-125b) exhibits context-dependent roles in cancer, acting as an oncogene or tumor suppressor.

Purpose of the Study:

• To systematically review and compile recent findings on the role of miR-125b in vascular diseases.
• To elucidate the pathogenic involvement and diagnostic potential of miR-125b in vascular pathologies.
• To present a computational analysis of the miR-125b regulatory network in vascular disease contexts.

Main Methods:

• Systematic literature retrieval from available reports on miR-125b and vascular diseases.
• Data summarization and analysis of retrieved studies.
• Computational bioinformatics to model the miR-125b target gene network.

Main Results:

• miR-125b is implicated as a pathogenic factor in various vascular diseases affecting endothelial and smooth muscle cells.
• miR-125b demonstrates potential as a diagnostic marker for vascular conditions.
• The complex network of miR-125b and its targets in vascular disease is computationally presented.

Conclusions:

• miR-125b is a significant player in the pathogenesis of endothelial and vascular smooth muscle cell-related vascular diseases.
• miR-125b holds promise as a valuable diagnostic biomarker for vascular diseases.
• Further research into the miR-125b network is warranted to understand its full impact on vascular health.